drugset / Trial / NCT01042236
Evaluation Of The Ability Of Fesoterodine To Increase Urethral Pressure In Stress Urinary Incontinence Patients
RandomizedCrossoverTriple-blindTreatment
Summary
The hypothesis under evaluation is that fesotorodine may provide clinical benefit in the treatment of the condition of stress urinary incontinence
Timeline
- Start
- 2009-01
- Primary completion
- 2010-07
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fesoterodine | Other / unclassified | 4 mg | — |
| Subject | Fesoterodine | Other / unclassified | 8 mg | — |